🇺🇸 FDA

Intelligence · Patent portfolio

NORTHWEST BIOTHERAPEUTICS Patents

Full USPTO pharma patent portfolio for NORTHWEST BIOTHERAPEUTICS — grant dates, expiration, and drug cross-links.

Patents
595
Expiring ≤24m
13

Quick answer

NORTHWEST BIOTHERAPEUTICS has 595 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 13 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 13

  1. US 12122811

    BDNF mimetic peptide amphiphiles

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12123036

    Soluble ACE2 variants and uses therefor

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12121608

    Biodegradable implant for sustained trans-nasal delivery of therapeutic agents to the brain

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12116574

    Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12116461

    Host-guest interactions for pa superstructure formation

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12108745

    Rat model of IgA nephropathy induced with a multimeric recombinant IgA fragment

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12098215

    Fusion protein construct

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12090209

    Twin base linkers for virus inactivation

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12083191

    Composition and methods for imaging cells

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12083113

    Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12060398

    Fibrous proteinaceous networks and methods of use thereof

    Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12042543

    Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhancer zeste homolog 2 (EZH2) and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of EZH2

    Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12036234

    Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11998589

    PEGylated peptide amphiphile nanofibers and methods of use

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11998635

    Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11993569

    3-amino-4-halocyclopentene carboxylic acids as inactivators of aminotransferases

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11964000

    Cancer treatment methods using nanofiber stabilized growth factors

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11959082

    Dual activity super toxic RNAi active dsRNAs

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11951124

    Tellurium nanowires with anticancer properties synthesized by green chemistry

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11952370

    Selective ligands for modulation of GIRK channels

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11911178

    System and method to detect and treat arrhythmogenic regions in atrial fibrillation

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11904025

    Cyclophanes for live-cell imaging

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11890290

    Topical treatment of wounds with statins and cholesterol for scar reduction

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11890346

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-MYC protein

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11891638

    Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11890353

    Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11883535

    Liposomal particles, methods of making same and uses thereof

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11865186

    Gene therapy treatment of atrial fibrillation

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11857531

    Combination mast cell inhibition for treatment of BPH/LUTS

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11859020

    Insulin like growth factor binding protein bioactive peptide fragments

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11851490

    Methods and compositions for treating, inhibiting, and/or preventing heterotopic ossification

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11850328

    Body temperature-triggered, in situ forming biomaterials and devices

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11850325

    Injectable, bioadhesive cryogel scaffolds for biomedical uses

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11839659

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11826407

    Peptide conjugated particles

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11820870

    Photocontrolled dynamic covalent linkers for polymer networks

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11801229

    Molecular entrapment via homopolymer self-assembly

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11793816

    Methods for enhancing cytotoxic cancer therapy through inhibition of ATG4B

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11786542

    Methods for enhancing cytotoxic cancer therapy through modulation of purine biosynthesis pathways

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11767500

    Systems for producing cellular immunotherapeutics and methods of use thereof

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11737978

    Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11723961

    Maspin, maspin derivatives, and maspin mimetics for reducing ROS, inflammation, and skin aging

    Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11701338

    Use of gTso thal in manufacturing medicament for promotion of MS-275 to cross blood-brain barrier

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11696896

    Immunomodulatory nanoparticle treatment of brain injury

    Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11690920

    General and direct method for preparing oligonucleotide-functionalized metal-organic framework nanoparticles

    Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11684570

    Pharmaceutical ophthalmic compositions

    Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11680062

    3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of Alzheimer's disease

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11672794

    Therapeutic targeting of the BAP1 complex in cancer

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does NORTHWEST BIOTHERAPEUTICS have?

595 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do NORTHWEST BIOTHERAPEUTICS patents expire?

13 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.